Cardiol Therapeutics Inc. (TSE:CRDL – Get Free Report)’s stock price traded up 1.6% on Thursday . The stock traded as high as C$1.94 and last traded at C$1.93. 130,571 shares were traded during mid-day trading, an increase of 33% from the average daily volume of 98,254 shares. The stock had previously closed at C$1.90.
Cardiol Therapeutics Stock Performance
The stock has a market cap of C$222.47 million, a P/E ratio of -4.95 and a beta of 0.27. The stock has a fifty day simple moving average of C$1.60 and a 200-day simple moving average of C$1.61. The company has a quick ratio of 6.84, a current ratio of 4.39 and a debt-to-equity ratio of 0.48.
Cardiol Therapeutics (TSE:CRDL – Get Free Report) last released its quarterly earnings data on Monday, May 11th. The company reported C($0.10) earnings per share for the quarter. Equities analysts expect that Cardiol Therapeutics Inc. will post -0.49 earnings per share for the current fiscal year.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc ( NASDAQ: CRDL ) ( TSX: CRDL ) is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. The Company’s lead small-molecule drug candidate, CardiolRx¿, modulates inflammasome pathway activation, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with pericarditis, myocarditis, and heart failure. The MAVERIC Program is evaluating CardiolRx¿ for the treatment of recurrent pericarditis, an inflammatory disease of the pericardium associated with symptoms including debilitating chest pain, shortness of breath, and fatigue, which can lead to physical limitations, reduced quality of life, emergency department visits, and hospitalizations.
Further Reading
- Five stocks we like better than Cardiol Therapeutics
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
